Try a single issue or save on a subscription Issues delivered straight to your door or device ...

The FDA approved Zepbound (tirzepatide) as the first prescription medication specifically for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. People taking Zepbound lost ...

There are many consequences of untreated OSA, and all of these are more likely with more-severe obstruction. Because people ...

Sleep apnea affects millions globally, often lurking undetected until it begins impacting overall health. While high blood ...

Snoring can be hard to sleep through, whether you're the person snoring or the partner listening to it all night. From nasal strips to specialty pillows, there are a lot of tools out there to stop ...

Since sleep apnea affects nearly a billion people worldwide, and using a CPAP machine (the standard treatment for sleep apnea) can be cumbersome, the approval by the Food and Drug Administration ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound ...

Sleep apnea is a condition that causes repeated cycles of breathing interruptions during sleep. If left untreated, sleep apnea may lead to dangerous health complications related to oxygen deprivation.

Eli Lilly's popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, CNBC reported on ...

The first medication for obstructive sleep apnea has been approved by the U.S. Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly's Zepbound ...